The effect of mannitol on oxygenation and creatine kinase MB release in patients undergoing multivessel off-pump coronary artery bypass surgery  by Shim, Jae Kwang et al.
T
M
c
J
K
Cardiopulmonary Support and Physiology Shim et al
7
CSPhe effect of mannitol on oxygenation and creatine kinase
B release in patients undergoing multivessel off-pump
oronary artery bypass surgery
ae Kwang Shim, MD,a Seung Ho Choi, MD,a,b Young Jun Oh, MD,a,b Chang Seok Kim, MD,ayung Jong Yoo, MD, PhD,c,d and Young Lan Kwak, MD, PhDa,b,d
O
b
c
a
a
t
u
c
M
g
P
a
s
o
r
R
w
I
s
n
t
C
u
p
c
O
p
g
o
i
r
i
a
d
oFrom the Department of Anesthesiology
and Pain Medicine,a Anesthesia and Pain
Research Institute,b Department of Tho-
racic and Cardiovascular Surgery,c and
Yonsei Cardiovascular Research Institute,d
Yonsei University College of Medicine,
Seoul, South Korea.
Received for publication July 21, 2006; re-
visions received Oct 9, 2006; accepted for
publication Oct 18, 2006.
Address for reprints: Young Lan Kwak,
MD, PhD, Department of Anesthesiology
and Pain Medicine and Anesthesia and Pain
Research Institute, Yonsei University Col-
lege of Medicine, 134 Shinchon-Dong,
Seodaemun-Ku, Seoul, South Korea, 120-
725 (E-mail: ylkwak@yumc.yonsei.ac.kr).
J Thorac Cardiovasc Surg 2007;133:704-9
0022-5223/$32.00
Copyright © 2007 by The American Asso-
ciation for Thoracic Surgerym
doi:10.1016/j.jtcvs.2006.10.017
04 The Journal of Thoracic and Cardiobjectives: Despite avoiding cardiopulmonary bypass, off-pump coronary artery
ypass surgery is associated with reduction in PaO2 and postoperative respiratory
ompliance. Also, transient interruption of coronary flow is necessary during distal
nastomoses and may impose ischemia-reperfusion myocardial injury. Mannitol is
n osmotic diuretic with free radical scavenging properties, and we have evaluated
he effects of mannitol on oxygenation and cardiac enzyme release in patients
ndergoing multivessel off-pump bypass surgery in a prospective, randomized,
ontrolled, double-blind trial.
ethods: Fifty patients were randomly allocated to receive either 20% mannitol 0.5
/kg (n  25) or normal saline 2.5 mL/kg (n  25) during Y-graft construction.
ulmonary variables and serum sodium concentrations were measured 15 minutes
fter induction of anesthesia and sternum closure. Creatine kinase MB was mea-
ured before and after the operation. Intraoperative and postoperative fluid input and
utput, time to extubation, and intraoperative hemodynamic variables were also
ecorded.
esults: PaO2 after sternum closure was significantly higher in the mannitol group,
ith faster time to extubation and shorter length of stay in the intensive care unit.
ntraoperative urine output was significantly greater in the mannitol group, without
ignificant differences in fluid input, serum sodium concentration, and hemody-
amic variables. Number of patients with a creatine kinase MB level more than 3
imes the upper limit of normal was significantly higher in the control group.
onclusion: Mannitol could be safely used without adverse side effects in patients
ndergoing multivessel off-pump bypass surgery with beneficial effects in terms of
reserving oxygenation, earlier extubation, and fewer patients with significant
reatine kinase MB elevation.
wing to advances in stabilization devices, surgical technique, and anesthetic
management strategies, multivessel off-pump coronary artery bypass sur-
gery (OPCAB) has gained increased popularity, with safety and early graft
atency comparable with those of conventional on-pump coronary artery bypass
rafting (CABG).1,2 Also, increasing numbers of studies have validated advantages
f OPCAB over on-pump CABG with regard to shorter postoperative stay in the
ntensive care unit (ICU), less transfusion requirement, and lower cardiac enzyme
elease.2-4 Cardiopulmonary bypass (CPB) has been shown to induce systemic
nflammatory response, producing increased pulmonary endothelial permeability
nd parenchymal damage.5,6 Despite avoiding CPB, OPCAB is associated with
ecreases in PaO2, pulmonary compliances, and pulmonary function similar to
n-pump CABG, which may lead to delayed extubation necessitating strategies for
inimizing postoperative pulmonary impairment.7,8 In addition, temporary inter-
vascular Surgery ● March 2007
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Puption of the coronary blood flow for bloodless anasto-
otic conditions may cause various degrees of myocardial
amage. Although the period of target vessel occlusion is
sually confined to approximately 15 minutes, multiple
rafts may impose cumulative ischemia-reperfusion myo-
ardial injury.9,10
Mannitol is an osmotic diuretic with free radical scav-
nging properties used in many fields of medicine.11-13
uring cardiac surgery, it can be administered in the pump
rime and cardioplegic solution and has been shown to
ignificantly decrease the wet weight of the lung after CPB
nd to reduce the extent of myocardial damage.14-18 How-
ver, there have been no studies validating the safety and
ffects of mannitol in patients undergoing OPCAB. There-
ore, we have evaluated the cardiopulmonary effects of
annitol in patients undergoing multivessel OPCAB with
egard to pulmonary compliances, PaO2, time to extubation,
nd creatine kinase MB (CK-MB) level in a prospective,
andomized, controlled, double-blind trial.
atients and Methods
fter approval of the institutional review board and patients’
onsent, 50 patients scheduled for elective multivessel OPCAB
etween January and June of 2006 were studied. Patients with
re-existing pulmonary and/or renal disease, serum creatinine level
reater than 1.3 mg/dL, left ventricular ejection fraction less than
0%, unstable angina, and recent myocardial infarction within 1
onth were excluded.
All patients received 0.05 to 0.1 mg/kg of morphine intramus-
ularly as premedication 1 hour before the operation. On arrival in
he operating room, standard monitoring devices were applied,
ncluding a pulmonary artery catheter (Swan-Ganz CCOmbo
CO/SvO2; Edwards LifeSciences, Irvine, Calif), which was in-
erted via the right internal jugular vein before induction of anes-
hesia. Anesthesia was induced with intravenous midazolam (2.0–
.0 mg) and sufentanil (1.5–3.0 g/kg) and maintained with
soflurane (0.6%–1%) and continuous infusion of sufentanil (0.5–
.5 g · kg1 · min1). Neuromuscular blockade was achieved by
dministering rocuronium (0.9 mg/kg) and maintained with con-
inuous infusion of vecuronium (1–2 g · kg1 · min1). Isosor-
ide dinitrate 0.5 g · kg1 · min1 was infused in all patients
hroughout the study period. The patients’ lungs were ventilated
ith a tidal volume of 10 mL/kg, an inspiratory/expiratory ratio of
Abbreviations and Acronyms
CABG  coronary artery bypass grafting
CK  creatine kinase
CPB  cardiopulmonary bypass
ICU  intensive care unit
Na  sodium
OPCAB off-pump coronary artery bypass surgery
PCWP  pulmonary capillary wedge pressure.9, and an inspiratory pause 10% of total inspiration time at a rate w
The Journal of Thoracicf 8 to 12 breaths/min in 60% oxygen with air and no positive
nd-expiratory pressure during the operation. After induction of
nesthesia, a transesophageal echocardiography probe was inserted
o detect newly developing segmental wall motion abnormalities.
ntravascular volume replacement was managed with crystalloid
nd colloid solutions to maintain the pulmonary capillary wedge
ressure (PCWP) between 8 and 14 mm Hg according to the
aseline values before enucleation of the heart. Central tempera-
ure measured by a pulmonary artery catheter was maintained
bove 36°C with a warm mattress, forced warm air blanket, and
uid warmer as necessary.
After the arterial grafts were harvested, the patients were ran-
omly allocated to receive either 0.5 g/kg of 20% mannitol (man-
itol group, n  25) or 2.5 mL/kg of normal saline (control group,
 25) using a computer-generated randomization table. Infusion
as done over 10 minutes during the period of composite Y-graft
onstruction, and all medical personnel involved in this study were
linded to the content of the infusate bottle.
All surgical procedures were performed by one surgeon
hrough a median sternotomy, and the heart was displaced with
posterior pericardial stitch, large (12  70 cm) gauze swabs,
nd a tissue stabilizer (Octopus Tissue Stabilization System;
edtronic, Inc, Minneapolis, Minn). The sequence of grafting was
lways the left anterior descending coronary artery first, followed
y the left circumflex coronary artery and the right coronary artery.
uring the period of heart displacement, mean systemic arterial
ressure was maintained above 60 to 70 mm Hg either with a 10°
o 20° Trendelenburg position and/or norepinephrine infusion. Cell
alvage was used during the operation in all cases, and salvaged
lood was reinfused to the patient before the end of the operation.
llogenic packed red blood cells were transfused when the hemo-
lobin level was less than 8 mg/dL throughout the study period.
ll patients were transferred to the ICU after the operation.
Dynamic and static pulmonary compliances (S/5 Anesthesia
onitor; Datex-Ohmeda Inc, Helsinki, Finland) and PaO2 and
erum sodium (Na) level were recorded 15 minutes after induc-
ion of anesthesia (baseline) and sternum closure. CK-MB levels
ere measured 24 hours before surgery and 12 and 24 hours after
urgery. Among the 2 postoperative values, the highest value was
ecorded and also the number of patients with CK-MB elevations
reater than 3 times the upper limit of normal (15 ng/mL) was
ecorded. Clinical diagnostic criteria for perioperative myocardial
nfarction were new Q waves of greater than 0.04 mm or a
eduction in R waves greater than 25% in at least 2 leads, or both,
ew ST elevation in at least 2 contiguous leads measuring more
han 0.2 mV in leads V1 to V3 or more than 0.1 mV in all other
eads, or new left bundle branch block.19 Hemodynamic variables
ncluding heart rate, mean arterial pressure, central venous pres-
ure, mean pulmonary arterial pressure, PCWP, cardiac index, and
ixed venous oxygen saturation were recorded 15 minutes after
he induction of anesthesia (baseline), 10 minutes after infusion of
ither mannitol or normal saline before enucleation of the heart, 10
inutes after stabilizer application for left circumflex coronary
rtery grafting, and 15 minutes after sternum closure. Amount of
nfused fluids and urine output during the operation and 12 hours
n the ICU postoperatively were recorded. The amount of infused
orepinephrine during the operation was also recorded. Extubation
as managed according to the standard ICU protocols by the ICU
and Cardiovascular Surgery ● Volume 133, Number 3 705
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CSPtaff, consisting of cardiothoracic surgeons and anesthesiologists
ot aware of this study, and time to extubation was recorded. The
riteria for tracheal extubation included an appropriate sensorium,
emodynamic stability with no significant chest tube bleeding,
aO2 greater than 80 mm Hg with an inspired oxygen fraction of
.4, PaCO2 less than 45 mm Hg, and reversal of neuromuscular
lockade. The length of stay in the ICU was also recorded.
Statistical analyses were performed with SPSS 12.0 software
SPSS, Inc, Chicago, Ill). All data are expressed as number of
atients or mean  SD. We determined that 24 patients would be
equired in each group with 90% power to detect a 50 mm Hg
ifference in PaO2 between the groups with an SD of 50 mm Hg
nd an alpha level of .05 using an independent t test. Data between
he groups were compared with the 2 test, Fisher exact test, or
ndependent t test as appropriate. Changes between time points
ithin the groups were compared by the paired t test or repeated-
easures analysis of variance with post hoc comparison using the
unnett test as appropriate.
esults
PCAB could be successfully performed in all patients
ithout conversion to on-pump CABG or any newly devel-
ped segmental wall motion abnormalities after grafting and
ostoperative electrocardiographic changes indicative of
yocardial infarction. None of the patients required inotro-
ic support during the perioperative period. Also, during the
tay in the ICU postoperatively, none of the patients had any
eurologic, hepatic, or renal complications. Patients’ char-
cteristics and operative data were similar between the
roups (Tables 1 and 2).
Dynamic and static pulmonary compliances were signif-
cantly decreased compared with baseline values in both
roups after sternum closure without any intergroup differ-
nces (Table 3). After sternum closure, PaO2 was signifi-
antly decreased only in the control group compared with
aseline value (P  .0001) and was significantly higher in
ABLE 1. Patient characteristics
Control group
(n  25)
Mannitol group
(n  25)
ge (y) 63 8 63 8
ender (M/F) 9/16 9/16
ody surface area (m2) 1.7  0.1 1.7 0.2
iabetes (n) 10 10
ypertension (n) 13 11
reoperative medication (n)
-Blockers 19 18
Calcium channel blockers 12 13
ACEIs 14 12
VEF (%) 63 11 62 11
ata are expressed as mean  SD or number of patients, and all P values
ere not significant. ACEIs, Angiotensin-converting enzyme inhibitors;
VEF, left ventricular ejection fraction.he mannitol group (P  .0001 for T2 and  .0001 for
*
m
06 The Journal of Thoracic and Cardiovascular Surgery ● Marc2–T1, Table 3*). Time to extubation was significantly
aster in the mannitol group (P  .002, Table 3). The length
f stay in the ICU was also significantly shorter in the
annitol group (P  .0001). Postoperative CK-MB level
as significantly increased in both groups compared with
he preoperative level and was lower in the mannitol group
ithout statistical significance (P.058 for T2 and .062 for
2–T1, Table 3). Number of patients with CK-MB eleva-
ions greater than 3 times the upper limit of normal was
ignificantly greater in the control group (P .022, Table 3).
rine output during the operation was significantly greater
n the mannitol group (P  .0001); however, total amount
f infused fluids and net fluid balance were all similar
etween the groups (Table 4). Serum Na level showed no
ignificant changes between the groups throughout the study
eriod (Table 4).
Hemodynamic variables were comparable between the
roups except the central venous pressure, mean pulmonary
rterial pressure, and PCWP, which were significantly lower
n the mannitol group during left circumflex coronary artery
rafting (Table 5). In contrast to the control group, mean
ulmonary arterial pressure and PCWP of the mannitol
roup did not significantly increase during left circumflex
rafting compared with baseline values (Table 5).
iscussion
nfusion of mannitol before grafting during multivessel
PCAB yielded beneficial effects with regard to preserva-
ion of PaO2 during the intraoperative period, faster time to
xtubation, and shorter length of stay in the ICU without
ABLE 2. Operative data
Control group
(n  25)
Mannitol group
(n  25)
peration time (min) 370 56 371  66
o. of grafts per patient 3.2 0.9 3.5  0.8
otal anastomosis time (min) 52 19 53  18
AD anastomosis (n) 25 25
Intracoronary shunt (n) 25 25
Anastomosis time (min) 16 6 17  6
Cx anastomosis (n) 24 21
Intracoronary shunt (n) 17 14
Anastomosis time (min) 17 5 15  4
CA anastomosis (n) 20 18
Intracoronary shunt (n) 14 11
Anastomosis time (min) 16 8 15 5
mount of infused NE (g) 292 270 286  272
ata are expressed as mean  SD or number of patients, and all P values
ere not significant. LAD, Left anterior descending coronary artery; LCx,
eft circumflex coronary artery; RCA, right coronary artery; NE,
orepinephrine.T0, 1 day before surgery; T1, 15 minutes after induction of anesthesia; T2, 15
inutes after sternum closure; T24, 24 hours after surgery.
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Pffecting total amount of infused fluids, net fluid balance,
erum Na concentration, and hemodynamics. In addition,
significantly greater number of patients had CK-MB ele-
ations more than 3 times the upper limit of normal in the
ontrol group, and, although without statistical significance,
here was a trend toward less postoperative CK-MB release
n patients treated with mannitol.
ABLE 3. Pulmonary variables and CK-MB level
ynamic lung compliance (mL/cm H2O)
tatic lung compliance (mL/cm H2O)
aO2 (mm Hg, FIO2 of 0.6)
ime to extubation (min)
ength of stay in the ICU (d)
K-MB (ng/mL)
T
K-MB elevation  3  the upper limit of normal (n)
ata are expressed as number of patients or mean SD. T1, 15 minutes aft
urgery; T24, 24 hours after surgery; FIO2, inspired oxygen fraction; ICU, in
t T1 or T0 in each group; †P  .05 between the groups.
ABLE 4. Fluid balance and serum sodium level
Control group
(n  25)
Mannitol group
(n  25)
ntraoperative
Input (mL)
Crystalloid 2483 879 2742 867
Colloid 1039 313 1110 305
pRBCs (u/n) 14/8 11/6
Urine output (mL) 727 314 1202 521*
Net balance (mL) 2795 900 2698 1077
ostoperative 12 h
Input (mL)
Crystalloid 2407 816 2339 576
pRBCs (u/n) 1/1 0/0
Urine output (mL) 1267 544 983 428
CT drainage (mL) 296 127 406 249
Net balance (mL) 450 700 761 241
erum sodium (mEq/L)
T1 141 2 142  2
T2 141 3 141  2
ata are expressed as mean  SD or number of units/number of patients
u/n). pRBCs, Packed red blood cells; CT, chest tube; T1, 15 minutes after
nduction of anesthesia; T2, 15 minutes after sternum closure; *P  .05oetween the groups.
The Journal of ThoracicDespite avoiding CPB, OPCAB is associated with a
ecrease in PaO2 and pulmonary function similar to on-
ump CABG with no difference in time to extubation.7,8
lso, interruption of coronary blood flow for bloodless
nastomoses during multivessel OPCAB may impose cu-
ulative ischemia-reperfusion myocardial injury.9,10 There-
ore, strategies for minimizing pulmonary impairment and
yocardial injury should be considered.
Mannitol is an osmotic diuretic with free radical scav-
nging properties widely used in the field of cardiac surgery,
dministered in doses ranging from 0.25 to 1.5 g/kg. It can
e administered in the pump prime and cardioplegic solu-
ion with beneficial effects on the kidneys, lungs, brain, and
eart.13,20 It has been shown to decrease lung water content
nd maintain pulmonary function after CPB by its osmotic
iuretic action and to limit ischemia-induced thromboxane
ynthesis.14,15 In addition, mannitol is associated with tran-
ient increase in coronary blood flow and cardiac output and
eduction in the extent of myocardial damage through its
ydroxyl radical scavenging properties.16-18,21,22 Mannitol
lso decreases the blood viscosity and may enhance micro-
irculation.23 Therefore, we have hypothesized that mannitol
ay exert favorable effects with regard to preserving oxygen-
tion and decreasing cumulative ischemia-reperfusion myocar-
ial injury in patients undergoing multivessel OPCAB. How-
ver, experience using mannitol during OPCAB is limited and
annitol is not free of side effects. During mannitol-induced
smotic diuresis, usually more water than Na is lost and
ay lead to hypovolemia and hypernatremia.11 Also, owing
o its acute plasma volume expansion effect, rapid infusion
Control group (n  25) Mannitol group (n  25)
38 7 38 8
33 8* 34 7*
1 4.2  5.6 4.3  6.7
53 14 52 11
49 13* 46 10*
1 6.0  10.8 5.3  8.3
233 50 218 41
169 57* 221 39†
1 63  59 4  48†
703 294 483 125†
2.6 0.7 1.6 0.5†
2.2 0.9 2.2 0.8
11.7 11.5* 7.0 2.9*
0 9.7 11.9 4.9  2.9
6† 0
uction of anesthesia; T2, 15 minutes after sternum closure; T0, 1 day before
e care unit; CK-MB, creatine kinase MB. *P  .05 compared with valuesTime
T1
T2
T2–T
T1
T2
T2–T
T1
T2
T2–T
T0
T24
24–T
er ind
tensivf mannitol may precipitate congestive heart failure.12
and Cardiovascular Surgery ● Volume 133, Number 3 707
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CSPIn this study, even though intraoperative urine output
as significantly increased in the mannitol group, total fluid
nd net fluid balance in the intraoperative as well as in the
ostoperative period were similar between the groups.
mount of infused norepinephrine during the operation and
a level before and after mannitol or normal saline infu-
ion were also similar between the groups. In addition,
entral venous pressure, PCWP, and other hemodynamic
ariables showed no clinically significant differences be-
ween the groups. Regarding these results, preserved oxy-
enation in the mannitol group may be attributable to os-
otic diuresis and subsequent reduction of increased
nterstitial water content of the lung without eliciting hypo-
olemia or adverse hemodynamic effects. Even though we
ould not observe any significant differences in pulmonary
ompliances at the end of the operation between the groups,
he finding that time to extubation was significantly faster in
he mannitol group can be regarded as an important clinical
enefit of mannitol infusion. However, the results of this
tudy should not be extended to patients with compromised
enal clearance. The theoretical volume of distribution of
annitol is the entire extracellular space and is rapidly
liminated almost exclusively by renal clearance.11,12
herefore, it may be sequestered in the interstitial space and
ay cause an increase in extravascular water content in case
f impaired renal clearance.
Elevation in CK-MB level greater than 3 times the upper
imit of normal after on-pump CABG or percutaneous cor-
nary intervention has been shown to be associated with
ncreased mortality.24-26 The fact that none of the patients in
he mannitol group and a significantly greater number of
ABLE 5. Hemodynamic data
Group (n  25, each)
R (beats/min) Control 59
Mannitol 62
AP (mm Hg) Control 73
Mannitol 77
PAP (mm Hg) Control 17
Mannitol 16
VP (mm Hg) Control 9
Mannitol 8
CWP (mm Hg) Control 12
Mannitol 12
vO2(%) Control 80
Mannitol 81
I (L · min1 · m2) Control 2.9
Mannitol 3.0
ata are expressed as mean  SD. T0, 15 minutes after induction of anes
inutes after stabilizer application for circumflex grafting; T3, 15 minutes a
ulmonary arterial pressure; CVP, central venous pressure; PCWP, pulmona
ndex. *P  .05 compared with values at T0 in each group; †P  .05 betwatients in the control group had a CK-MB level more than r
08 The Journal of Thoracic and Cardiovascular Surgery ● Marctimes the upper limit of normal despite similar preopera-
ive and intraoperative characteristics between the groups
an also be considered as a beneficial effect of mannitol.
lthough there was a trend toward less CK-MB release in
he mannitol group, the finding that there was no statistically
ignificant difference in CK-MB levels between the groups
ay be attributable to multiple factors. In our study, intra-
oronary shunt has been used during left anterior descend-
ng coronary artery grafting in all patients and also in some
atients during left circumflex and right coronary artery
rafting. Even though the numbers were similar between the
roups, since intracoronary shunt provides some distal flow
uring grafting procedure, this might have affected our
esult.27 The concentration and timing of mannitol infusion
ight have affected the result as well. Free radical genera-
ion is greatest during early postischemic reperfusion; there-
ore, infusion at the start of reperfusion should yield the
reatest effect in terms of myocardial preservation.17,18 In
ontrast to on-pump CABG, where the application and
elease of aortic crossclamping is most responsible for
yocardial ischemia-reperfusion injury, various degrees
f ischemia-reperfusion injury may result at each grafting
uring OPCAB.9,10 Considering immediate onset and an
limination half-life of 2 to 4 hours, we thought it would be
ost appropriate to infuse mannitol just before the first
rafting procedure. However, the optimal concentration and
iming of mannitol infusion with regard to myocardial pro-
ection can be a limitation of this study. In addition, con-
idering the difference in SD of the postoperative CK-MB
alues between the groups, a larger sample size may be
T1 T2 T3
61  9 67  12* 68  12*
64  8 70  13* 74  12*
74  11 78 10 77  10
1 76 13 76 8 81 11
18  4 21  5* 17  3
18  4 18  5† 16  3
8  2 12  3* 9  3
8  2 10  3*† 8  2
12  3 15  5* 13  3
12  3 13  3† 11  3
82  6 67  9* 74  7*
82  6 65  11* 73  7*
.5 2.6 0.4 2.0  0.3* 2.6  0.4*
.6 2.8 0.5 2.1  0.4* 2.6  0.4*
a; T1, 10 minutes after infusion of either mannitol or normal saline; T2, 10
ernum closure; HR, heart rate; MAP, mean arterial pressure; MPAP, mean
pillary wedge pressure; SvO2, mixed venous oxygen saturation; CI, cardiac
group comparisons at each time point of measurement.T0
 7
 7
 9
 1
 4
 3
 3
 2
 4
 3
 4
 3
 0
 0
thesi
fter st
ry caequired to be well powered.
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PAnother limitation of this study is that we have excluded
atients with pre-existing lung parenchymal disease, unsta-
le angina, and decreased left ventricular ejection fraction
ho might be more susceptible to significant postoperative
mpairment of oxygenation and increase in cardiac enzyme
elease. Whether the same efficacy and safety can be ob-
erved in these patients needs to be validated through fur-
her studies.
In conclusion, mannitol could be safely used without
dverse side effects in patients undergoing multivessel
PCAB with favorable effects on oxygenation, time to
xtubation, length of stay in the ICU, and CK-MB release.
herefore, infusion of mannitol may be considered as a
otential therapeutic modality for preserving oxygenation
ith myocardial protective effect in patients without im-
aired renal clearance undergoing multivessel OPCAB.
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